PPT-1 Training Protocol For Emergency Glucagon Providers

Author : harmony | Published Date : 2022-06-01

Updated September 2018 Introduction ORS 433800433830 Allows for the administration of epinephrine for anyone experiencing a severe allergic reaction Allows for

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "1 Training Protocol For Emergency Glucag..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

1 Training Protocol For Emergency Glucagon Providers: Transcript


Updated September 2018 Introduction ORS 433800433830 Allows for the administration of epinephrine for anyone experiencing a severe allergic reaction Allows for the administration of Glucagon for an individual with a prescription for Glucagon suffering from severe hypoglycemia. There are different types of emergency contraception the emergency contraceptive pill Levonelle the emergency contraceptive pill ellaOne the emergency intrauterine device IUD Emergency contraception can be very effective IWTIGMEPPMJSYLEZIER9XXIHSVMJ Students with Type 1 Diabetes. December 6 . 2013. Purpose. To train designated school staff how to recognize low blood sugar and administer glucagon for treatment of severe low blood sugar.. Learning Objectives. If the student is transported by bus, a school employee must accompany and be trained on the proper administration of glucagon in case of an emergency.. KBN 2014. When is Glucagon needed?. When the student is unable to swallow, or unconscious!. GO TO THE AMERICAN DIABETES . ASSOCIATION . SAFE AT SCHOOLS VIDEO CHAPTER . 6 . – . GLUCAGON ADMINISTRATION. on the . internet at YOU TUBE: . http://. www.youtube.com/watch?v=OC-dcDgmXuI&feature=share&list=EC3DE9DDE8EB2A2E56. Silu Zuo, Pharm.D.. PGY1 Pharmacy Resident. UW Medicine. Patient Case. CC: JT is a 53 y/o female presenting to ED with . profound hypoglycemia and . unresponsiveness during nuclear medicine study. HPI: . Morphology of . t. he Endocrine. Pancreas. The . human pancreas . contains 1 . to 2 million islets . of Langerhans which range . in size from about 50 to about . 500 mm. Collectively the islets make up only 1 to . Knowledge Just over three-quarters of providers were familiar with oral PrEP, while 23% had not heard of it (Figure 2). The most common sources of information were the national guidelines/policy and other healthcare workers. . Understanding the Emergency Preparedness Final Rule. Caecilia Blondiaux. Survey & Certification Group. Centers for Medicare & Medicaid Services. Final Rule. Medicare and Medicaid Programs; Emergency Preparedness Requirements for Medicare and Medicaid Participating Providers and Suppliers. Pancreatic gland and its hormones. Asso. . Professor Dr Than . Kyaw. 24 September 2012. The pancreas. Pancreas – both exocrine and endocrine functions. Exocrine function. . - associated with digestion. Islets of Langerhans. 2. Glucagon. Insulin. Somatostatin. Exocrine portion. Islets of Langerhans. The islets of Langerhans (1% to 2% of the pancreatic . mass):. 1. Beta cells. : most . abundant cell . Failure to take insulin. Failure to increase insulin. Illness/Infection. Pneumonia. MI. Stroke. Acute stress. Trauma. Emotional. Medical Stress. Counterregulatory hormones. Oppose insulin. Stimulate glucagon release. S63 | Vol 69, No 7 | SEPTEMBER 2020 Recognition and Management of Hypoglycemia Jay H Shubrook, DO, FAAFP, FACOFP “Hypoglycemia is the major limiting factor in the glycemic management of t 6], and it is also considered to occur in humans [Based upon this hypothesis, glucagon has been given for treating low cardiac output disorders [], but the inotropic eect of glucagon in the human hea various, non-pharmacological challenges to glucose regulated pathways (e.g. intravenous glucose, meals, glucagon and . incretins. ). Mean data from three clinical studies (LEAD-3, LEAD-6 and AWARD-6), in which the effect of liraglutide (a GLP-1 agonist) on glucose and insulin was investigated, were also added to the dataset. An overview of the data is shown in Figure 2 under the Results section..

Download Document

Here is the link to download the presentation.
"1 Training Protocol For Emergency Glucagon Providers"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents